Skip to Content

health-news.click

health-news.click

  • Home
  • rss

Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial Mandated

15 January 2026 No Comments

New Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of permission to Johnson & Johnson Pvt. Ltd. to import and market…

Diabetes risk not associated with timing or type of menopause: Study

15 January 2026 No Comments

Women aged younger than 45 years who experience menopause are at a higher risk of coronary heart disease and stroke. However, despite such diabetes-related risk factors as increased fat and…

Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy: Study

15 January 2026 No Comments

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the…

Subcutaneous Anifrolumab Improves Outcomes in Systemic Lupus Erythematosus: Phase 3 trial

15 January 2026 No Comments

Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with systemic lupus erythematosus (SLE). In the phase 3 TULIP-SC trial, anifrolumab met its primary BICLA endpoint…

Sleeping less than 7 hours could cut years off your life, reveals study

15 January 2026 No Comments

Getting a full night of sleep may play a larger role in longevity than many people realize. New research from Oregon Health & Science University indicates that regularly getting too…

Cardiovascular Risk Score Predicts Future Serious Eye Disease Risk: Study

15 January 2026 No Comments

USA: A new study, published in Ophthalmology, has revealed that the Pooled Cohort Equations cardiovascular risk score—which integrates age, sex, blood pressure, cholesterol levels, and smoking status to estimate 10-year…

FDA Approves First At-Home Brain Neuromodulation Device for Depression

15 January 2026 No Comments

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment for adults whose depression has not responded adequately to antidepressants. Developed by Neurolief, the…

Rosuvastatin Shows Cardiovascular Edge but Higher Albuminuria Risk in Diabetic CKD: Study Shows

15 January 2026 No Comments

China: A large real-world study from Hong Kong suggests that rosuvastatin and atorvastatin have comparable effects on progression to end-stage kidney disease (ESKD) in Chinese patients with diabetes. While rosuvastatin…

Low Vitamin D Linked to Higher Death and Heart Risk in Lupus Patients: Study

15 January 2026 1 Comment

USA: Researchers have reported that low vitamin D levels are strongly linked to a higher risk of death and cardiovascular complications in patients with systemic lupus erythematosus (SLE), highlighting a…

Pediatrics & Neonatology Conferences in 2026: International Events Calendar

15 January 2026 No Comments

Child and neonatal health remains a significant global and national priority, serving as a crucial indicator of a nation's well-being and developmental progress. Annually, millions of infants worldwide are affected…

Posts pagination

1 … 321 322 323 … 379

« Previous Page — Next Page »

TOP SITES
ALL-NEWS.CLICK
BUSINESS-NEWS.CLICK
FINANCE-NEWS.CLICK
HEALTH-NEWS.CLICK
SCIENCE-NEWS.CLICK
SPORT-NEWS.CLICK
TECHN-NEWS.CLICK
CATEGORIES
WORLD NEWS
HEALTH
BUSINESS
CRYPTO
SPORTS
SCIENCE
TECHNOLOLOGY
STORIES
POLITICS

health-news.click

Copyright © All rights reserved | Blogus by Themeansar.